Pembrolizumab Versus Placebo as Adjuvant Therapy in Resected Stage IIB or IIC Melanoma: Final Analysis of Distant Metastasis-Free Survival in the Phase III KEYNOTE-716 Study.
Resource Type
Article
Authors
Luke, Jason J. ; Ascierto, Paolo A. ; Khattak, Muhammad A. ; de la Cruz Merino, Luis ; Del Vecchio, Michele ; Rutkowski, Piotr ; Spagnolo, Francesco ; Mackiewicz, Jacek ; Chiarion-Sileni, Vanna ; Kirkwood, John M. ; Robert, Caroline ; Grob, Jean-Jacques ; de Galitiis, Federica ; Schadendorf, Dirk ; Carlino, Matteo S. ; Wu, Xi Lawrence ; Fukunaga-Kalabis, Mizuho ; Krepler, Clemens ; Eggermont, Alexander M.M. ; Long, Georgina V.
Source
Journal of Clinical Oncology; 5/10/2024, Vol. 42 Issue 14, p1619-1624, 10p
Subject
Language
ISSN
0732183X